WHO ICTRP trial
An exploratory study to investigate the effect of FE 999302 when given together…
CTIS2023-507630-25-00 · EU Clinical Trials Information System · Recruiting
Key facts
| Trial ID | CTIS2023-507630-25-00 |
|---|---|
| Public title | An exploratory study to investigate the effect of FE 999302 when given together with follitropin delta during controlled ovarian stimulation |
| Scientific title | - 000426 |
| Primary sponsor | Ferring Pharmaceuticals A/S |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): Yes Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | Norway;Belgium;Spain;Czechia;Denmark |
| Conditions | Infertility in women undergoing assisted reproductive technologies (ART);Therapeutic area: Diseases [C] - Female Urogenital Diseases and Pregnancy Complications [C13] |
| Registration date | Feb 2, 2024 |
| Target size | 600 |
| Secondary IDs | U1111-1293-5452 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: